State Street’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135K Hold
17,595
﹤0.01% 3920
2026
Q1
$145K Hold
17,595
﹤0.01% 3963
2025
Q4
$194K Hold
17,595
﹤0.01% 3910
2025
Q3
$314K Hold
17,595
﹤0.01% 3767
2025
Q2
$367K Hold
17,595
﹤0.01% 3683
2025
Q1
$305K Buy
17,595
+2,800
+19% +$58.1K ﹤0.01% 3730
2024
Q4
$282K Buy
14,795
+2,613
+21% +$79.7K ﹤0.01% 3770
2024
Q3
$820K Hold
12,182
﹤0.01% 3517
2024
Q2
$125K Buy
12,182
+500
+4% +$5.4K ﹤0.01% 3944
2024
Q1
$126K Sell
11,682
-900
-7% -$9.87K ﹤0.01% 3985
2023
Q4
$95.9K Sell
12,582
-1
-0% -$7 ﹤0.01% 4065
2023
Q3
$108K Hold
12,583
﹤0.01% 4099
2023
Q2
$139K Sell
12,583
-54,076
-81% -$661K ﹤0.01% 4118
2023
Q1
$881K Buy
66,659
+2,073
+3% +$30.6K ﹤0.01% 3569
2022
Q4
$814K Buy
64,586
+8,589
+15% +$424K ﹤0.01% 3609
2022
Q3
$5.42M Buy
55,997
+9,721
+21% +$1.11M ﹤0.01% 3017
2022
Q2
$4.28M Buy
46,276
+3,513
+8% +$498K ﹤0.01% 3170
2022
Q1
$9.19M Buy
42,763
+4,684
+12% +$1.09M ﹤0.01% 2871
2021
Q4
$13M Buy
38,079
+23,434
+160% +$9.05M ﹤0.01% 2760
2021
Q3
$5.24M Buy
14,645
+2,142
+17% +$800K ﹤0.01% 3214
2021
Q2
$4.83M Buy
+12,503
New +$4.64M ﹤0.01% 3262

Other funds holding TIL

State Street's TIL Position: Q2 2026 in Review

State Street held its Instil Bio (TIL) position steady in Q2 2026 at 17,595 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #3920.

State Street first reported a position in TIL in Q2 2021 and has held it in 21 quarters since. The position peaked at $13M in Q4 2021. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • State Street held 17,595 shares of Instil Bio worth $135K as of Q2 2026.
  • State Street left its Instil Bio share count unchanged in Q2 2026.
  • Instil Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3920 holding.
  • State Street first reported a position in Instil Bio in Q2 2021 and has held it in 21 quarters since.
  • State Street's Instil Bio position peaked at $13M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.